Welcome to our dedicated page for Zoetis SEC filings (Ticker: ZTS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Zoetis Inc. (ZTS) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Zoetis, described as the world’s leading animal health company, uses filings such as Form 8-K to report material events related to its operations, financing activities, governance and shareholder returns.
Recent 8-K filings detail several types of information. Zoetis has reported the completion of a private offering of 0.25% Convertible Senior Notes due 2029, including the terms of the notes, their conversion features, optional redemption provisions and related capped call transactions. Other filings describe the issuance of senior notes due 2028 and 2035 under an existing indenture, as well as a revolving credit agreement that provides a senior unsecured revolving credit facility and replaces a prior credit agreement.
Filings also cover corporate actions affecting shareholders, such as declarations of cash dividends on Zoetis common stock and the use of proceeds from financing transactions to repurchase shares under an existing share repurchase program. Additional 8-Ks report quarterly financial results, guidance updates, and investor presentations, including an Innovation Webcast that outlines the company’s pipeline and strategic approach to addressing unmet medical needs in animals.
Through this page, users can review how Zoetis discloses information about its NYSE-listed common stock, debt obligations, credit facilities and board-level decisions. Stock Titan’s platform associates these filings with AI-powered tools that summarize key terms and highlight items such as note covenants, leverage provisions, dividend declarations and event-driven disclosures, helping readers interpret lengthy documents more efficiently.
Zoetis Inc. executive Kevin Esch reported routine equity compensation activity. On February 6 and 8, 2026, he acquired 43 and 50 shares of Zoetis common stock, respectively, through the vesting and settlement of restricted stock units.
On those same dates, he disposed of 15 and 18 shares of common stock at $127.42 per share. Following these transactions, he directly held 327 shares of Zoetis common stock and indirectly held 122.9323 common stock equivalents in the Zoetis Savings Plan, a 401(k) plan, as of December 31, 2025. He also reported outstanding restricted stock units covering 44, 307.4298 and 775.5724 shares of common stock, subject to multi‑year vesting schedules tied to continued service.
Zoetis Inc. executive Ashton Nicholas reported routine equity activity tied to restricted stock units (RSUs). On February 6, 2026, 381 shares of common stock were acquired upon RSU vesting, with 200 shares withheld at $127.42 per share for taxes, leaving 1,275 shares directly owned. On February 8, 2026, 398 shares were acquired from additional RSU vesting, with 209 shares withheld at $127.42, resulting in 1,464 common shares held directly after these transactions. Nicholas also holds 2,250.4257 RSUs, each representing a contingent right to receive one Zoetis common share as they vest over multi‑year schedules.
Zoetis Inc. Executive Vice President Roxanne Lagano reported routine equity compensation activity involving restricted stock units and common shares. On February 6, 2026, 544 shares of common stock were acquired upon RSU vesting, and 217 shares were withheld at a price of $127.42 for tax obligations. On February 8, 2026, a further 605 shares were acquired upon RSU vesting, with 221 shares withheld at $127.42 for taxes.
Following these transactions, Lagano directly owned 15,140 shares of Zoetis common stock and held 833.684 common stock equivalents indirectly through the Zoetis Savings Plan, a 401(k) plan, as of December 31, 2025. She also held 2,250.4257 RSUs that vest in installments on the first, second, and third anniversaries of the respective grant dates, subject to continued service and certain earlier-vesting events.
Zoetis Inc. Chief Financial Officer Joseph Wetteny reported equity award activity and tax-related share withholding. On February 6, 2026, 1,388 restricted stock units vested and were settled into common shares, with 515 shares withheld at $127.42 per share for taxes. On February 8, 2026, another 1,409 units vested into common shares, with 483 shares withheld at $127.42 per share for taxes. After these transactions, Wetteny directly owned 20,766 shares of Zoetis common stock and held 6,152.6517 RSUs that remain outstanding.
Zoetis Inc. Executive Vice President Ferran Astorga Jeannette reported routine equity compensation activity involving restricted stock units (RSUs) and common stock. On February 6 and 8, 2026, RSUs vested and were settled into 206 and 218 shares of Zoetis common stock, respectively, with no cash exercise price.
To cover withholding obligations, the company withheld 92 and 97 shares of common stock at a price of $127.42 per share. After these transactions, the executive directly held 1,443 shares of Zoetis common stock and 1,294.6543 RSUs, which each represent a contingent right to receive one share of common stock as they vest over future anniversaries of the original grant dates.
Zoetis Inc. Executive Vice President Jamie Brannan reported routine equity compensation activity. On February 6 and 8, 2026, restricted stock units (RSUs) vested and were settled in Zoetis common stock, resulting in acquisitions of 529 and 380 shares, respectively.
To cover tax withholding on these vestings, 249 shares on February 6 and 179 shares on February 8 were withheld at a price of $127.42 per share. After these transactions, Brannan directly owned 2,652 shares of Zoetis common stock and held 445 common stock equivalents indirectly through the UK Share Ownership Plan.
The filing also shows 3,614.0741 RSUs outstanding under the Zoetis Amended and Restated 2013 Equity and Incentive Plan and related dividend equivalents, which represent contingent rights to receive the same number of Zoetis common shares upon future vesting.
Zoetis Inc. Executive Vice President Rimma Driscoll reported routine equity compensation activity involving restricted stock units (RSUs) and common stock. On February 6, 2026, 222 shares of common stock were acquired upon RSU vesting, and 89 shares were withheld at a price of $127.42 per share to cover taxes, leaving 5,325 shares of common stock directly owned. On February 8, 2026, a further 192 shares were acquired upon RSU vesting, with 77 shares withheld at $127.42 per share for taxes, resulting in 5,440 directly owned shares. The derivative table shows related RSU positions, including ongoing RSU awards that vest in thirds on the first, second, and third anniversaries of the original grant dates.
Zoetis Inc. Executive Vice President Keith Sarbaugh reported routine equity compensation activity. On February 6, 2026, 119 shares of common stock were acquired upon vesting and settlement of restricted stock units, and 48 shares were withheld at $127.42 per share to cover taxes.
After these transactions, Sarbaugh directly owns 2,110 shares of Zoetis common stock. He also holds time-based restricted stock units that each represent a contingent right to receive one share, including 120 RSUs from a February 6, 2024 grant, 1,528.0167 RSUs from a March 31, 2023 grant, and 1,159.7099 RSUs from a February 19, 2025 grant, all vesting in three equal annual installments subject to continued service.
Zoetis Inc. Chief Executive Officer and director Kristin C. Peck reported multiple equity transactions involving company stock and restricted stock units (RSUs). On February 6, 2026, RSU vesting led to the acquisition of 5,555 shares of common stock, followed by the disposition of 1,914 shares at $127.42 per share. On February 8, 2026, additional RSUs vested, generating 6,224 shares of common stock, with 2,722 shares disposed of at $127.42 per share.
After these transactions, Peck directly held 101,337 shares of Zoetis common stock and 833.6435 common stock equivalents in the Zoetis Savings Plan (401(k)) as of December 31, 2025, along with 22,062.8977 RSUs outstanding under the company’s equity incentive plan.
Zoetis Inc. declared a quarterly dividend of $0.53 per share for the second quarter of 2026. The dividend will be paid on June 2, 2026 to shareholders of record as of the close of business on April 20, 2026. The company also noted that the related information is being furnished under Regulation FD and not treated as filed for liability purposes.